Replies to post #10875 on GTC Biotherapeutics (fka GTCB)

[croumagnon]

"I think its partnering or buyout or bankruptcy"

I do not think Bankrupcy is in the cards. The company can always tighten its spending, go to the pink sheets if necessary, and even do horrible financing deals at lower and lower prices to stay in existence. Management wants to keep their cushy jobs and they do have a product on the market, so I do not think bankrupcy is a possibility...

That leaves us with either a partnering announcement soon or a buyout on the cheap. Let's hope we see that partnership deal soon...

[DragonBits]

oky, which is harder to kill, vampires or biotechs? You don't see many biotechs actually go BK.

For GTC, it would make no sense, they have enough assets that even including their debt they could get bought out at some price greater than zero.

So I think worst case is another dilutive financing.

This is like some private companies that are formed with the idea that they will have an IPO. Those that invest in the beginning often have to pony up more cash as the company develops or they get diluted out of existence. Then they have to hope that the eventual IPO will reward them.

The reason they do the RS is it is far easier to do a financing on the NASD than it would be on a the BB.

The thing about GTC, it still reminds me of Imatron, just too many shares outstanding for it's stage of development.

But I would hold out hope for a another partner.

[DewDiligence]

>…does nothing to raise capitol.<

The capitol is in Boston and it’s already tall enough, IMO. If anyone tries to raise it, the folks on Beacon Hill will surely complain about the obstructed view.